Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.07
INFU's Cash to Debt is ranked lower than
54% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.07 vs. INFU: 0.07 )
INFU' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.07

Equity to Asset 0.56
INFU's Equity to Asset is ranked higher than
67% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. INFU: 0.56 )
INFU' s 10-Year Equity to Asset Range
Min: 0.51   Max: 0.73
Current: 0.56

0.51
0.73
Interest Coverage 1.69
INFU's Interest Coverage is ranked lower than
54% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. INFU: 1.69 )
INFU' s 10-Year Interest Coverage Range
Min: 0.6   Max: 9999.99
Current: 1.69

0.6
9999.99
F-Score: 7
Z-Score: 1.54
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.38
INFU's Operating margin (%) is ranked higher than
84% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. INFU: 13.38 )
INFU' s 10-Year Operating margin (%) Range
Min: -121.45   Max: 13.67
Current: 13.38

-121.45
13.67
Net-margin (%) 4.73
INFU's Net-margin (%) is ranked higher than
73% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.99 vs. INFU: 4.73 )
INFU' s 10-Year Net-margin (%) Range
Min: -83.17   Max: 28.12
Current: 4.73

-83.17
28.12
ROE (%) 7.32
INFU's ROE (%) is ranked higher than
74% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.72 vs. INFU: 7.32 )
INFU' s 10-Year ROE (%) Range
Min: -72.53   Max: 13.38
Current: 7.32

-72.53
13.38
ROA (%) 4.08
INFU's ROA (%) is ranked higher than
75% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.08 vs. INFU: 4.08 )
INFU' s 10-Year ROA (%) Range
Min: -43.99   Max: 8.56
Current: 4.08

-43.99
8.56
ROC (Joel Greenblatt) (%) 36.45
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
88% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. INFU: 36.45 )
INFU' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -318.97   Max: 40.32
Current: 36.45

-318.97
40.32
Revenue Growth (%) 5.70
INFU's Revenue Growth (%) is ranked higher than
76% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. INFU: 5.70 )
INFU' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 87.9
Current: 5.7

0
87.9
EBITDA Growth (%) 18.00
INFU's EBITDA Growth (%) is ranked higher than
86% of the 221 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. INFU: 18.00 )
INFU' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 18
Current: 18

0
18
» INFU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

INFU Guru Trades in Q4 2013

Whitney Tilson Sold Out
» More
Q1 2014

INFU Guru Trades in Q1 2014

Mario Gabelli 28,980 sh (New)
» More
Q2 2014

INFU Guru Trades in Q2 2014

Mario Gabelli 28,980 sh (unchged)
» More
Q3 2014

INFU Guru Trades in Q3 2014

Mario Gabelli 28,980 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with INFU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-03-31 New Buy$2.12 - $2.98 $ 2.757%28980
Whitney Tilson 2013-12-31 Sold Out 0.2%$1.32 - $2.21 $ 2.7557%0
Whitney Tilson 2013-09-30 New Buy0.2%$1.3 - $1.81 $ 2.7587%10000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 18.70
INFU's P/E(ttm) is ranked higher than
91% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.00 vs. INFU: 18.70 )
INFU' s 10-Year P/E(ttm) Range
Min: 2.73   Max: 178
Current: 18.7

2.73
178
P/B 1.38
INFU's P/B is ranked higher than
90% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.38 vs. INFU: 1.38 )
INFU' s 10-Year P/B Range
Min: 0.33   Max: 1.98
Current: 1.38

0.33
1.98
P/S 0.93
INFU's P/S is ranked higher than
91% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.74 vs. INFU: 0.93 )
INFU' s 10-Year P/S Range
Min: 0.36   Max: 6.18
Current: 0.93

0.36
6.18
EV-to-EBIT 9.78
INFU's EV-to-EBIT is ranked higher than
95% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.42 vs. INFU: 9.78 )
INFU' s 10-Year EV-to-EBIT Range
Min: -243.2   Max: 200.6
Current: 9.78

-243.2
200.6
Current Ratio 1.48
INFU's Current Ratio is ranked higher than
52% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. INFU: 1.48 )
INFU' s 10-Year Current Ratio Range
Min: 0.01   Max: 483.08
Current: 1.48

0.01
483.08
Quick Ratio 1.35
INFU's Quick Ratio is ranked higher than
62% of the 282 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. INFU: 1.35 )
INFU' s 10-Year Quick Ratio Range
Min: 0.01   Max: 483.08
Current: 1.35

0.01
483.08

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.00
INFU's Price/Tangible Book is ranked higher than
81% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.44 vs. INFU: 3.00 )
INFU' s 10-Year Price/Tangible Book Range
Min: 1.07   Max: 10.29
Current: 3

1.07
10.29
Price/DCF (Projected) 1.17
INFU's Price/DCF (Projected) is ranked higher than
93% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.64 vs. INFU: 1.17 )
INFU' s 10-Year Price/DCF (Projected) Range
Min: 0.26   Max: 1.3
Current: 1.17

0.26
1.3
Price/Median PS Value 0.97
INFU's Price/Median PS Value is ranked higher than
83% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.19 vs. INFU: 0.97 )
INFU' s 10-Year Price/Median PS Value Range
Min: 0.38   Max: 5.03
Current: 0.97

0.38
5.03
Price/Graham Number 1.63
INFU's Price/Graham Number is ranked higher than
91% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. INFU: 1.63 )
INFU' s 10-Year Price/Graham Number Range
Min: 0.87   Max: 2.61
Current: 1.63

0.87
2.61
Earnings Yield (Greenblatt) 10.20
INFU's Earnings Yield (Greenblatt) is ranked higher than
95% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. INFU: 10.20 )
INFU' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.5   Max: 10.4
Current: 10.2

0.5
10.4

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
InfuSystems Holdings, Inc, a Delaware corporation was formed on August 15, 2005. The Company is a provider of infusion pumps and related services in the United States. It provides its services to hospitals, oncology practices and facilities and other alternate site health care providers. The Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer. The Company provides these pumps and related supplies to oncology clinics, obtain an assignment of insurance benefits from the patient, and bill the patient's insurance company or patient as appropriate, for the use of the pump and supplies, and collect payment. It also provide pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics in the United States, while retaining title to the pumps during this process. The competition is primarily composed of regional DME providers, hospital-owned DME providers, physician providers and home care infusion providers. The operations comply with applicable federal, state and local environmental laws.
» More Articles for INFU

Headlines

Articles On GuruFocus.com
Applying Buffett’s Arbitrage Techniques to Infusystem Jul 31 2013 
InfuSystem Buyout Coming with 32% Upside Potential Jul 22 2013 
comment on INFU May 14 2013 
comment on INFU Apr 15 2013 
comment on INFU Jan 13 2013 
comment on INFU Jan 08 2013 
comment on INFU Jan 02 2013 

More From Other Websites
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 02 2014
INFUSYSTEM HOLDINGS, INC Financials Nov 15 2014
10-Q for InfuSystem Holdings, Inc. Nov 13 2014
Infusystem Holdings, Inc. to Participate in LD Micro Annual Conference Nov 13 2014
Infusystem Holdings, Inc. to Participate in LD Micro Annual Conference Nov 13 2014
Q3 2014 InfuSystem Holdings Inc Earnings Release - Before Market Open Nov 10 2014
InfuSystem Holdings, Inc. Reports Third Quarter Revenue of $16.6 Million and Net Profit of $0.04 Per... Nov 10 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 10 2014
InfuSystem Holdings, Inc. Reports Third Quarter Revenue of $16.6 Million and Net Profit of $0.04 Per... Nov 10 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Oct 30 2014
InfuSystem Holdings, Inc. to Issue Third Quarter 2014 Financial Results on Monday, November 10, 2014 Oct 30 2014
InfuSystem Holdings, Inc. to Issue Third Quarter 2014 Financial Results on Monday, November 10, 2014 Oct 30 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 01 2014
InfuSystem Holdings, Inc. Reports Second Quarter Revenue of $16.4 Million and Net Profit of $0.04... Aug 01 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 10 2014
InfuSystem Holdings, Inc. to Issue Second Quarter 2014 Financial Results on Friday, August 1, 2014 Jul 09 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 09 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... May 28 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... May 20 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 16 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK